We performed univariate and multivariate Cox regression analyses on this 11-gene panel by including various clinical variables (e.g., age, gender, stage) of bladder cancer patients, as well as the mutation status of TNN, TP53, and MUC16, which are the top 3 mutated genes in bladder cancer (Figure S3). Here, TP53 is linked to urinary bladder carcinoma.